Bard International

Bard International, now operating as BD Bard, evokes a complex and often polarized sentiment among its stakeholders. For many healthcare professionals, the brand is recognized for its long-standing history of innovation and essential medical devices, particularly in urology, vascular, and oncology. Products like catheters and vascular grafts are often seen as reliable and critical for patient care, contributing significantly to quality of life and life-saving interventions. However, the brand also carries a heavy burden of negative sentiment, primarily stemming from widespread litigation and patient complications associated with certain products, most notably surgical mesh and IVC filters. These issues have led to significant patient suffering, product recalls, and a perception of corporate negligence in some circles. Consequently, while the brand is respected for its medical contributions, it also faces considerable scrutiny and distrust from affected patients and their advocates, creating a dual narrative of essential medical provider and controversial product manufacturer.